India to United States: Atovaquone Export Trade Route

The India to United States Atovaquone corridor is one of India's established pharmaceutical export routes, with 212 shipments documented worth a combined $37.5M USD. The route is dominated by GLENMARK PHARMACEUTICALS LIMITED, which alone accounts for roughly 33% of all export value, reflecting the consolidated nature of India's atovaquone manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $176.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during January–March, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 11.9%, placing it at rank #14 among India's top atovaquone export destinations globally.

On the import side, key buyers of Indian atovaquone in United States include TO THE ORDER OF...., GLENMARK PHARMACEUTICALS INC USA, TO THE ORDER OF and 26 others. TO THE ORDER OF.... is the single largest importer with 49 shipments valued at $7.5M USD.

India's atovaquone exports to United States are driven primarily by a handful of large-scale manufacturers. GLENMARK PHARMACEUTICALS LIMITED with 66 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — GLENMARK PHARMACEUTICALS LIMITED, HETERO LABS LIMITED, HETERO LABS LIMITED — together account for 78% of total trade value on this route. The average shipment value of $176.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as atovaquone 750mg/5ml oral solution and atovaquone liquid syrup, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER OF.... is the largest importer with 49 shipments worth $7.5M USD — representing 20% of all atovaquone imports from India on this route. A total of 29 buyers are active on this corridor.